| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |